Mussel Protein Used to Develop New Vaccine Technology
Scientists in South Korea have developed a new adhesive adjuvant protein-based nanoparticle vaccine technology that they believe may provide longer-lasting immunity with a single injection. According to the researchers in a study published in the journal Biomaterials in 2026, the new approach used bioengineering, gene synthesis and cloning to create a new vaccine technology using […]
“Vaccines” for Honeybees and Shrimp?
Researchers are investigating whether feeding inactivated bacteria to invertebrates such as honeybees and shrimp can act as “vaccines” by causing epigenetic changes that prevent disease, even though invertebrates lack the immune system typically targeted by traditional vaccines.1 The first vaccine for honeybees has received conditional approval from the U.S. Department of Agriculture in 2023 and […]
New Dengue Vaccine Suspended in Brazil After Severe Adverse Event Reports
Brazil’s Ministry of Health and the National Health Surveillance Agency (ANVISA) suspended a mass vaccination campaign using a new dengue vaccine developed by a Brazilian biomedical research center after severe adverse events, including deaths, were associated with certain batches of the vaccine. Authorities have opened an investigation into the incidents while continuing to assess the […]
London Hospital Creates Innovative Outdoor Ward for Critically Ill Patients
A hospital in the United Kingdom has taken a historic step in patient care by introducing an outdoor medical environment to give critically ill patients access to sunlight, greenery and outdoor air.1 King’s College Hospital in south London recently opened a purpose-built rooftop critical care garden directly integrated into its intensive care infrastructure. This facility […]
Scientists Creating mRNA Biologics with Added Aluminum Adjuvant
Scientists at Boston Children’s Hospital in Massachusetts have developed an experimental mRNA biologic technology that they say produced longer-lasting immune responses in animal studies without the use of additional booster shots. The 2026 study was published in Nature Immunology.1 The research looked at a challenge in mRNA technology on how to make protection last longer […]
Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]